Therapeutic Solutions increases authorized shares from 5.5B to 6.5B via shareholder written consent

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

Certificate of Amendment filed Feb 20, 2024 raising authorized common stock from 5.5B to 6.5B shares.
Approved by majority written consent of shareholders on Feb 19, 2024.
Series A Preferred holder (Timothy G. Dixon, Thomas E. Ichim) retains effective voting control of the corporation.
Authorized preferred stock remains unchanged at 5M shares.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: Increased authorized common stock from 5,500,000,000 to 6,500,000,000 shares, par value $0.001 per share, and 5,000,000 shares of preferred stock, par value $0.001 per share (effective 2024-02-20).

Change: charter amendment
Effective: 2024-02-20

Exact text from the filing

On February 20, 2024, after gaining consent from a majority of voting shareholders, we caused to be filed with the Nevada Secretary of State a Certificate of Amendment to Articles of Incorporation to effect an amendment (the “Amendment”) increasing the aggregate number of shares which the corporation shall have authority to issue from 5,500,000,000 to 6,500,000,000 shares of stock having a $.001 par value per share, and 5,000,000 shares of Preferred Stock having a $.001 par value per share.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001493152-24-007443

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.